Institutional investors purchased a net $4.5 million shares of INCY during the quarter ended December 2014 and now own 98.19% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.3 Million shares of Incyte Corp
CAPITAL GUARDIAN TRUST CO. Bought 2.7 Million shares of Incyte Corp
SSGA FUNDS MANAGEMENT, INC. Bought 653.2 Thousand shares of Incyte Corp